DHT-UN 📈 DRI Healthcare Trust - Overview
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock •
DHT-UN: Pharmaceuticals, Royalties, Therapeutics
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada. Web URL: https://www.dricapital.com
Additional Sources for DHT-UN Stock
DHT-UN Stock Overview
| Market Cap in USD | 523m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| GiC Sub-Industry | Pharmaceuticals |
| IPO / Inception |
DHT-UN Stock Ratings
| Growth 5y | 37.2% |
| Fundamental | -35.2% |
| Dividend | 66.7% |
| Rel. Strength Industry | 1657 |
| Analysts | - |
| Fair Price Momentum | 11.86 CAD |
| Fair Price DCF | - |
DHT-UN Dividends
| Dividend Yield 12m | 4.30% |
| Yield on Cost 5y | 6.57% |
| Annual Growth 5y | 8.26% |
| Payout Consistency | 100.0% |
DHT-UN Growth Ratios
| Growth Correlation 3m | 3.2% |
| Growth Correlation 12m | -26.7% |
| Growth Correlation 5y | 74.5% |
| CAGR 5y | 11.59% |
| CAGR/Mean DD 5y | 0.48 |
| Sharpe Ratio 12m | 0.69 |
| Alpha | 6.00 |
| Beta | 1.08 |
| Volatility | 55.41% |
| Current Volume | 24.6k |
| Average Volume 20d | 52.3k |
What is the price of DHT-UN stocks?
As of December 22, 2024, the stock is trading at CAD 12.12 with a total of 24,573 shares traded.
Over the past week, the price has changed by -1.47%, over one month by +30.87%, over three months by +36.36% and over the past year by +40.96%.
As of December 22, 2024, the stock is trading at CAD 12.12 with a total of 24,573 shares traded.
Over the past week, the price has changed by -1.47%, over one month by +30.87%, over three months by +36.36% and over the past year by +40.96%.
Is DRI Healthcare Trust a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, DRI Healthcare Trust (TO:DHT-UN) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.16 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DHT-UN as of December 2024 is 11.86. This means that DHT-UN is currently overvalued and has a potential downside of -2.15%.
Probably not. Based on ValueRay Fundamental Analyses, DRI Healthcare Trust (TO:DHT-UN) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.16 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DHT-UN as of December 2024 is 11.86. This means that DHT-UN is currently overvalued and has a potential downside of -2.15%.
Is DHT-UN a buy, sell or hold?
DRI Healthcare Trust has no consensus analysts rating.
DRI Healthcare Trust has no consensus analysts rating.
What are the forecast for DHT-UN stock price target?
According to ValueRays Forecast Model, DHT-UN DRI Healthcare Trust will be worth about 13 in December 2025. The stock is currently trading at 12.12. This means that the stock has a potential upside of +7.43%.
According to ValueRays Forecast Model, DHT-UN DRI Healthcare Trust will be worth about 13 in December 2025. The stock is currently trading at 12.12. This means that the stock has a potential upside of +7.43%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 19.9 | 63.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 13 | 7.4% |